menu search

Wave life sciences third quarter 2023 financial results scheduled for november 9, 2023

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delive...

November 3, 2023, 8:05 pm

Prime medicine reports third quarter 2023 financial results and provides business updates

— Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as well...

November 3, 2023, 8:01 pm

Taysha gene therapies: tsha-102's potential is a 'buy'

Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...

November 3, 2023, 7:41 pm

Bruise treatment market size to reach usd 444 million by 2031, at a 3.5 % cagr | by tmr

Emerging trends in regenerative medicine and stem cell therapies are expected to offer innovative solut...

November 3, 2023, 12:30 pm

Biostem technologies closes oversubscribed $2m private placement

POMPANO BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative ...

November 3, 2023, 12:30 pm

Editas medicine (edit) reports q3 loss, tops revenue estimates

Editas medicine (EDIT) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Est...

November 3, 2023, 9:47 am

Astria therapeutics to present new star-0215 data at the 2023 american college of allergy, asthma, and immunology annual scientific meeting

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allerg...

November 3, 2023, 8:10 am

Cliff notes: a central bank trifecta

Key insights from the week that was. In Australia, nominal retail sales rose strongly in September, up 0.9% (2.0%yr). However, this was mostly due to ...

November 3, 2023, 5:22 am

Lexeo therapeutics announces pricing of initial public offering

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic ...

November 3, 2023, 1:51 am

Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc

– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIE...

November 2, 2023, 11:30 am

Global microfluidics market to touch us$ 23,739.1 million by 2033, registering an 11.9% cagr | fmi study

The microfluidics industry is poised for remarkable growth in the near future, driven by its diverse applications across healthcare, biotechnology, an...

November 2, 2023, 10:30 am

Editas medicine to present clinical data from the ruby and edithal trials of edit-301 at the ash 2023 annual meeting and in a company-sponsored webinar

Company to host a webinar to discuss EDIT-301 clinical data on Monday, December 11, at 1:00 p.m. ET Dr. Rabi Hanna from Cleveland Clinic Children's to...

November 2, 2023, 9:12 am

Mckesson lifts annual profit forecast after strong quarterly results

Drug distributor McKesson Corp on Wednesday raised its annual profit forecast, banking on strong demand for specialty medicines....

November 1, 2023, 6:27 pm

Siren biotechnology awarded $4m in grant funding from the california institute for regenerative medicine (cirm)

SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Siren Biotechnology, a gene therapy company pioneering Universal AAV Immuno-Gene Therapies for Cance...

November 1, 2023, 4:46 pm

Scholarship opportunity for aspiring medical pioneers: dr. zamip patel scholarships for future doctors

ORLANDO, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) — The pursuit of a career in medicine often embodies a ...

November 1, 2023, 3:55 pm

Gsk beats on q3 earnings and sales, raises 2023 guidance

GSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The company raises guidance for earnings and sales on ...

November 1, 2023, 12:47 pm

Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 ctos annual meeting

– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools –...

November 1, 2023, 10:30 am

Genetic toxicology testing market expected to reach a market value of us$ 4.56 billion: growing demand for personalized medicine spurs growth, according to persistence market research

The global genetic toxicology testing market is expected to grow rapidly in the coming years, driven by increasing demand from the pharmaceutical and ...

November 1, 2023, 10:04 am

Uk regulator approves pfizer's hair loss drug

Britain's medicines regulator on Wednesday approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease....

November 1, 2023, 7:39 am

How novo nordisk makes its weight-loss drug wegovy

Novo Nordisk is spending billions of dollars to boost output and ease shortages of its hugely popular, highly effective weight-loss ...

November 1, 2023, 6:18 am


Search within

Pages Search Results: